Article
Synthetic sickness or lethality points at candidate combination therapy targets in glioblastoma
30 Apr 2013
Abstract excerpt
Synthetic lethal interactions in cancer hold the potential for successful combined therapies, which would avoid the difficulties of single molecule-targeted treatment. Identification of interactions that are specific for human tumors is an open problem in cancer research. This work aims at deciphering synthetic sick or lethal interactions directly from somatic alteration, expression and survival data of cancer...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
